Search Results - "HIGHLEY, M. S"

Refine Results
  1. 1

    Treatment of Invasive Thymoma With Single-Agent Ifosfamide by HIGHLEY, M. S, UNDERHILL, C. R, HARPER, P. G, PARNIS, F. X, KARAPETIS, C, RANKIN, E, DUSSEK, J, BRYANT, B, ROWLAND, C, HODSON, N, HUGHES, J

    Published in Journal of clinical oncology (01-09-1999)
    “…To evaluate single-agent ifosfamide in the treatment of invasive thymoma. Fifteen patients (eight male and seven female) with histologically confirmed invasive…”
    Get full text
    Journal Article
  2. 2

    Hyphenated techniques in anticancer drug monitoring: II. Liquid chromatography–mass spectrometry and capillary electrophoresis–mass spectrometry by Guetens, G, De Boeck, G, Highley, M.S, Wood, M, Maes, R.A.A, Eggermont, A.A.M, Hanauske, A, de Bruijn, E.A, Tjaden, U.R

    Published in Journal of Chromatography A (08-11-2002)
    “…High-performance liquid chromatography has become the separation technique of choice for the monitoring of generally thermolabile anticancer agents. With the…”
    Get full text
    Book Review Conference Proceeding Journal Article
  3. 3
  4. 4

    Hyphenated techniques in anticancer drug monitoring: I. Capillary gas chromatography–mass spectrometry by Guetens, G, De Boeck, G, Wood, M, Maes, R.A.A, Eggermont, A.A.M, Highley, M.S, van Oosterom, A.T, de Bruijn, E.A, Tjaden, U.R

    Published in Journal of Chromatography A (08-11-2002)
    “…Most anticancer agents are relatively unstable substances and are subjected to intensive metabolism in vivo and degradation during sample pretreatment…”
    Get full text
    Book Review Conference Proceeding Journal Article
  5. 5

    Intravesical drug delivery : Pharmacokinetic and clinical considerations by HIGHLEY, M. S, VAN OOSTEROM, A. T, MAES, R. A, DE BRUIJN, E. A

    Published in Clinical pharmacokinetics (01-07-1999)
    “…Intravesical drug administration is widely used in the treatment of patients with superficial bladder cancer, and aims to optimise drug delivery in the…”
    Get full text
    Journal Article
  6. 6

    Activated oxazaphosphorines are transported predominantly by erythrocytes by Highley, M. S., Schrijvers, D., Van Oosterom, A. T., Harper, P. G., Momerency, G., Van Cauwenberghe, K., Maes, R. A. A., De Bruijn, E. A., Edelstein, M. B.

    Published in Annals of oncology (01-11-1997)
    “…purpose Oxazaphosphorines are metabolised by a variety of pathways, one of which leads to activation and the formation of alkylating compounds. However, the…”
    Get full text
    Journal Article
  7. 7

    Erythrocytes and the transport of drugs and endogenous compounds by HIGHLEY, M. S, DE BRUIJN, E. A

    Published in Pharmaceutical research (01-02-1996)
    “…This review considers the significance and measurement of endogenous compounds and drugs on erythrocytes. Part I examines literature examples where a direct…”
    Get full text
    Journal Article
  8. 8

    Combination chemotherapy with epirubicin, cisplatin and 5-fluorouracil for the palliation of advanced gastric and oesophageal adenocarcinoma by Highley, M S, Parnis, F X, Trotter, G A, Houston, S J, Penson, R T, Harper, P G, Mason, R C

    Published in British journal of surgery (01-12-1994)
    “…The palliative efficacy of laser therapy with combination chemotherapy (cisplatin, epirubicin and continuous infusion of 5-fluorouracil) was assessed in 34…”
    Get more information
    Journal Article
  9. 9

    Pharmacokinetics and bioavailability of oral 5′‐deoxy‐5‐fluorouridine in cancer patients by VAN DER HEYDEN, S. A. M, HIGHLEY, M. S, DE BRUIJN, E. A, TJADEN, U. R, REEUWIJK, H. J. E. M, VAN SLOOTEN, H, OOSTEROM, A. T. V, MAES, R. A. A

    Published in British journal of clinical pharmacology (01-04-1999)
    “…Aims Oral administration of 5‐fluorouracil (FUra), an important cytotoxic agent, is limited by a wide variation in bioavailability. 5′‐deoxy‐5‐fluorouridine…”
    Get full text
    Journal Article Conference Proceeding
  10. 10

    Multicenter phase II study of gemcitabine in previously untreated patients with advanced epithelial ovarian cancer by Underhill, C R, Parnis, F X, Highley, M S, Ahern, J, Harper, P G, Hansen, H, Lund, B, Dombernowsky, P, Hirsch, F, Hansen, M, Carmichael, J, Williams, C

    Published in Anti-cancer drugs (01-09-2001)
    “…Gemcitabine has activity in advanced ovarian cancer, with responses in platinum-resistant disease. This study assessed the activity of gemcitabine in…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Weekly cisplatin with oral etoposide: a well-tolerated and highly effective regimen in relapsed ovarian cancer by Verborg, W A, Campbell, L R, Highley, M S, Rankin, E M

    “…The optimal treatment of progressive ovarian cancer after first-line platinum-based therapy remains a challenge. We collected prospectively data on patients…”
    Get more information
    Journal Article
  13. 13
  14. 14
  15. 15

    Partitioning of ifosfamide and its metabolites between red blood cells and plasma by Momerency, G, Van Cauwenberghe, K, Highley, M S, Harper, P G, Van Oosterom, A T, De Bruijn, E A

    Published in Journal of pharmaceutical sciences (01-03-1996)
    “…A recently developed GC-MS analytical method for the quantitative determination of oxazaphosphorines and their metabolites in blood plasma, using stable…”
    Get more information
    Journal Article
  16. 16

    A Phase II Trial of Continuous 5-Fluorouracil in Recurrent or Metastatic Transitional Cell Carcinoma of the Urinary Tract by Highley, M.S, Griffiths, G.O, Uscinska, B.M, Huddart, R.A, Barber, J.B.P, Parmar, M.K.B, Harper, P.G

    “…Abstract Aims To assess the activity of a continuous infusion of 5-fluorouracil in patients with recurrent locally advanced or metastatic transitional cell…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Drugs prescribed for self poisoners by Prescott, L F, Highley, M S

    “…Of 230 adults admitted for self poisoning over two months, 153 (67%) had previously been taking a total of 309 prescribed drugs. Of these patients, 119 (78%)…”
    Get full text
    Journal Article
  19. 19

    Vascular Endothelial Growth Factor and Angiogenesis by Hoeben, Ann, Landuyt, Bart, Highley, Martin S, Wildiers, Hans, Van Oosterom, Allan T, De Bruijn, Ernst A

    Published in Pharmacological reviews (01-12-2004)
    “…Angiogenesis is a hallmark of wound healing, the menstrual cycle, cancer, and various ischemic and inflammatory diseases. A rich variety of pro- and…”
    Get full text
    Journal Article
  20. 20